Spots Global Cancer Trial Database for sph4336 tablets 400mg
Every month we try and update this database with for sph4336 tablets 400mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer | NCT05744687 | Locally Advance... | SPH4336 Tablets... SPH4336 Tablets... | 18 Years - 75 Years | Shanghai Pharmaceuticals Holding Co., Ltd |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
